Monoclonal Antibodies (mAbs) constitute the largest and most commercially successful segment within the Antibodies Market, serving as a pillar of modern biopharmaceuticals. These engineered antibodies are created to be identical and highly specific, targeting a single epitope on a specific antigen, which is often a protein on the surface of a cancer cell or an inflammatory mediator. This...